Clinical Trial Update: Safety and Tolerability of MORAb-022 in Healthy and Rheumatoid Arthritis Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and tolerability of MORAb-022 in healthy subjects and rheumatoid arthritis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MORAb-022

Snippet

Sponsor: Morphotek | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED